Compare Aventis Pharma with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs WYETH LTD - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA WYETH LTD SANOFI INDIA/
WYETH LTD
 
P/E (TTM) x 45.2 27.7 163.0% View Chart
P/BV x 8.3 5.3 154.8% View Chart
Dividend Yield % 1.1 1.3 82.6%  

Financials

 SANOFI INDIA   WYETH LTD
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
WYETH LTD
Mar-13
SANOFI INDIA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6,8401,044 654.9%   
Low Rs4,630818 566.0%   
Sales per share (Unadj.) Rs1,203.1298.6 403.0%  
Earnings per share (Unadj.) Rs165.357.2 288.7%  
Cash flow per share (Unadj.) Rs209.958.4 359.3%  
Dividends per share (Unadj.) Rs84.0017.00 494.1%  
Dividend yield (eoy) %1.51.8 80.2%  
Book value per share (Unadj.) Rs963.6249.5 386.3%  
Shares outstanding (eoy) m23.0322.72 101.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.1 152.8%   
Avg P/E ratio x34.716.3 213.3%  
P/CF ratio (eoy) x27.315.9 171.4%  
Price / Book Value ratio x6.03.7 159.4%  
Dividend payout %50.829.7 171.1%   
Avg Mkt Cap Rs m132,07821,157 624.3%   
No. of employees `0003.30.5 670.9%   
Total wages/salary Rs m4,068400 1,017.0%   
Avg. sales/employee Rs Th8,393.813,787.4 60.9%   
Avg. wages/employee Rs Th1,232.4813.0 151.6%   
Avg. net profit/employee Rs Th1,153.02,643.3 43.6%   
INCOME DATA
Net Sales Rs m27,7086,783 408.5%  
Other income Rs m897353 254.4%   
Total revenues Rs m28,6057,136 400.9%   
Gross profit Rs m6,2351,617 385.5%  
Depreciation Rs m1,02727 3,860.9%   
Interest Rs m76 127.3%   
Profit before tax Rs m6,0981,938 314.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m2,292632 362.5%   
Profit after tax Rs m3,8061,301 292.7%  
Gross profit margin %22.523.8 94.4%  
Effective tax rate %37.632.6 115.2%   
Net profit margin %13.719.2 71.6%  
BALANCE SHEET DATA
Current assets Rs m15,9226,984 228.0%   
Current liabilities Rs m6,2352,056 303.3%   
Net working cap to sales %35.072.6 48.1%  
Current ratio x2.63.4 75.2%  
Inventory Days Days6499 64.1%  
Debtors Days Days2124 87.2%  
Net fixed assets Rs m7,539244 3,086.0%   
Share capital Rs m230227 101.2%   
"Free" reserves Rs m21,9625,441 403.7%   
Net worth Rs m22,1925,668 391.5%   
Long term debt Rs m025 0.0%   
Total assets Rs m29,8397,901 377.7%  
Interest coverage x872.1353.3 246.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.9 108.2%   
Return on assets %12.816.5 77.3%  
Return on equity %17.222.9 74.7%  
Return on capital %27.534.0 80.8%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m7,58715 49,914.5%   
Fx outflow Rs m7,1452,677 266.9%   
Net fx Rs m442-2,662 -16.6%   
CASH FLOW
From Operations Rs m3,739923 405.0%  
From Investments Rs m-731317 -230.7%  
From Financial Activity Rs m-1,972-481 410.0%  
Net Cashflow Rs m1,036759 136.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 51.1 118.2%  
Indian inst/Mut Fund % 14.4 11.3 127.4%  
FIIs % 14.6 7.2 202.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 30.4 34.5%  
Shareholders   15,184 21,978 69.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SHASUN PHARMA  DR. REDDYS LAB  TORRENT PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Trades Positive, Crude Oil Sees Buying, FPI Equity Inflows Rise, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended marginally lower yesterday as benchmark indices gave up early gains and slipped into the red during the last hour of trading.

Related Views on News

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 26, 2020 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS